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Abstract
Here we discuss a case of arrhythmia-induced cardiomyopathy (AIC) with consecutive severe multiple organ failure. In relation
to this imposing case, we discuss the signiﬁcance of this potentially underestimated cause of newly occurred left-ventricular
systolic dysfunction and concomitant arrhythmia. We further delineate the diagnostic algorithm and differential diagnoses
of AIC.
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Introduction
Arrhythmia-induced cardiomyopathy (AIC) represents a po-
tentially reversible condition of left-ventricular (LV) systolic
dysfunction (LVSD), which is caused by atrial or ventricular
tachycardia/arrhythmias.1,2 As rhythm disorders are often
regarded as consequences of LVSD in daily clinical practice,
AIC appears to be an underestimated cause of heart failure,
particularly when ‘idiopathic dilated cardiomyopathy’ with
concomitant arrhythmia is diagnosed. Here, we present a
drastic case of AIC-induced multiple organ failure, underlining
the importance of AIC as a differential diagnosis that requires
quick initiation of an indispensable aggressive anti-arrhythmic
therapy.
Case report
We report the case of a 51-year-old man with acute onset of
multiple organ failure who was transferred to our clinic from
an external hospital with the diagnosis acute liver failure with
decreasing vigilance, jaundice, hypoglycaemia, and oedema.
During emergency transferral, hypotension and tachycardia
(190 bpm) were noted. In the emergency department, vaso-
pressor therapy was initiated and tracheal intubation was
necessary because of depressed level of consciousness.
Abdominal ultrasound imaging revealed bilateral pleural effu-
sion and hepatic vein congestion. A prominent acute hepato-
cellular injury, acute renal failure, coagulation disorder, and
high levels of NT-pro-BNP were found (Figure 1A). While
the general state of health of the patient did not improve de-
spite medical treatment, the patient was considered for list-
ing as high urgency liver transplantation candidate. The
calculated MELD score (Model of End-Stage Liver Disease)
was 40 points, signifying a very high risk of 3 month mortality
in patients awaiting liver transplantation.3,4 However, tho-
racic and abdominal contrast-enhanced computed tomogra-
phy showed cardiac enlargement, ascites, anasarca, and
inhomogeneous contrast enhancement of the liver (nutmeg
liver), pointing to hepatic venous congestion due to cardiac
failure. In light of this ﬁnding, echocardiography was per-
formed and a severely impaired left-ventricular ejection frac-
tion (LVEF) of 10–15% was found. Moreover, as biomarkers
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for cardiac ischaemia (hs-Troponin I, CK-MB, and CK) were
markedly elevated, timely coronary angiography was realized
and coronary artery disease as a cause of LVSD was excluded.
In addition, upon careful electrocardiogram inspection, the
cardiologist suspected typical atrial ﬂutter and not sinus
tachycardia to be the cause of the persistent elevation in
heart rate (now ~130 bpm). As rhythm disorders are known
to constitute an underlying cause of LVSD, electrical cardio-
version was conducted (Figure 1B) after exclusion of left-
atrial thrombi by transesophageal echocardiography on Day
3. Cardiac magnetic resonance imaging (MRI) performed on
Day 5 showed a dilation of all four cavities (LV end-diastolic
diameter of 6.8 cm and right-ventricular end-diastolic
diameter of 5.7 cm), relevant tricuspid and mitral valve
regurgitation, a severely impaired LVEF (16%) with global
hypokinesia, but no myocardial oedema or signiﬁcant ventric-
ular late gadolinium enhancement (Figure 2 and Supporting
Information, Video S1). Left-ventricular endomyocardial bi-
opsy, performed on Day 6, could further rule out myocarditis,
rheumatological, or lysosomal storage disease and showed
mild hypertrophic myocardium with enlarged nuclei and irrel-
evant subendocardial accentuated ﬁbrosis. Furthermore, no
signiﬁcant increase of CD3 positive lymphocytes was ob-
served, but higher numbers of CD68 positive macrophages
were detected in immunohistological stainings. The expres-
sion of major histocompatibility complex II was moderately
enhanced. Ultrastructurally, an increased number of mito-
chondria was obvious in the neighbourhood of the interca-
lated discs (Figure 2B). The clinical state of the patient as
well as liver function, coagulation, and renal function rapidly
improved after restoration of sinus rhythm (Figure 1A). The
patient was extubated on Day 8. During the following days,
medical heart failure therapy was adjusted and the clinical
state of the patient subsequently further improved. An
Figure 1 (A) Time course of important laboratory ﬁndings revealing a recovery of initially affected organ functions. (B) Surface electrocardiogram
showing tachycardiac atrial ﬂutter and successful restoration of normofrequent sinus rhythm after electrical cardioversion. GOT, glutamic oxaloacetic
transaminase; GPT, glutamic pyruvic transaminase; INR, international normalized ratio.
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Figure 2 (A) Short tau inversion recovery sequence in short cardiac axis of initial magnetic resonance imaging (left). Despite artefacts due to large
pleural effusions, myocardial oedema can be excluded. Late-enhancement sequence in four-chamber view of follow-up magnetic resonance imaging
(right). There is no pathological late enhancement, hence no evidence of myocardial scar or ﬁbrosis. (B) Histology revealed mild hypertrophic
cardiomyocytes with enlarged nuclei and a mild subendocardial ﬁbrosis in the haematoxylin and eosin staining (a, ×200); immunohistologically isolated
CD3 positive lymphocytes could be found in the interstitium (b, ×200); an increased positivity for major histocompatibility complex II was evident (c) as
well as a slight increased number of CD68 positive macrophages (d). Ultrastructurally, increased number of mitochondria near the intercalated discs
was found (e); in the interstitium, macrophages could be shown (f).
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echocardiographic control on Day 11 also revealed an im-
provement of LVEF (34%). On Day 18, ﬁrst adequate commu-
nication was possible. Detailed anamnesis revealed that the
patient had been physically healthy beforehand but was
suffering from daily ‘panic attacks’ with sudden intense
palpitations and heart race during the past 12 months. An
outpatient electrocardiogram has never been performed.
Interestingly, the patient did not experience any similar epi-
sodes after conversion to sinus rhythm. Another cardiac
MRI on Day 25 showed further improvement in LVEF (40%;
Supporting Information, Video S2) as well as a reduction
of cardiac chamber dilation (LV end-diastolic diameter of
6.3 cm and right-ventricular end-diastolic diameter of
4.8 cm). Tricuspid and mitral valve regurgitation was not
detectable anymore. As other causes of LVSD were ruled
out and diagnostic criteria for AIC were fulﬁlled, AIC due to
sustained atrial ﬂutter was regarded as cause of LVSD and
consecutive multiple organ failure. To ensure long-term
rhythm control, radiofrequency ablation of the cavotricuspid
isthmus was performed on Day 33. Finally, the patient was in-
troduced to our outpatient clinic and was discharged from
hospital on Day 36.
Discussion
This case report demonstrates that severe LVSD can be
caused by AIC and may eventually lead to multiple organ
failure.1,5 Diagnostic criteria for AIC are unexplained LVSD
with concomitant arrhythmia and partial or complete recov-
ery of LV function after restoration of sinus rhythm.1,2 In
the present case, these criteria were fulﬁlled and alternative
causes of LVSD were carefully ruled out. Absence of ventric-
ular late gadolinium enhancement on cardiac MRI served as
supportive diagnostic criteria for AIC, as it was shown to be
associated with a greater improvement of LV function in
this context (Supporting Information, Videos S1 and S2).6
Furthermore, increased inﬁltration of CD68 positive macro-
phages, enhanced major histocompatibility complex II ex-
pression, and increased numbers of mitochondria at the
intercalated discs were found in LV endomyocardial biopsy
samples of the patient. These were also recently shown to
be speciﬁc for AIC.2 Conclusively, diagnosis of AIC was con-
ﬁrmed after restoration of sinus rhythm and early improved
LV function within days to weeks. Nevertheless, it is well ac-
cepted that full recovery of LV function may last from
weeks to months up to more than a year.1 Importantly,
rhythm control and subsequent increment of LV function
also resulted in a fast recovery of the other compromised
organ functions, illustrating the closed connection of the
liver, kidney, and AIC.
In most of the cases of newly diagnosed LVSD, rhythm dis-
orders are regarded as consequences of LVSD. Although
typical atrial ﬂutter as it occurs in this case report is rarely
caused by LVSD, AIC generally raises a ‘chicken or egg’ ques-
tion. Frequently, the arrhythmia is considered secondary
and is not treated effectively when, in fact, arrhythmia control
may be necessary for recovery of LV function.1 Accordingly,
AIC appears to be an underestimated cause of LVSD. In the
present case, the diagnosis of AIC was discarded several times
and replaced by ‘idiopathic dilated cardiomyopathy’. This
approach is in our opinion typical for the disease and may
be explained by a lack of awareness and/or knowledge about
AIC. Very recent trials underline the relevant incidence and
importance of AIC. In fact, in the CAMERA-MRI study, 54% of
enrolled patients with previous structural heart disease and
88% of patients with idiopathic DCM, all suffering from atrial
ﬁbrillation (AF) and LVSD, ﬁnally turned out to have a relevant
component of AIC.6 In another study of 1269 patients who
underwent atrial ﬂutter ablation, AIC was observed in 56%
of the patients with concomitant LVSD.7 Furthermore, it was
recently demonstrated that restoration of sinus rhythm with
catheter ablation in patients with AF and LVSD results in sig-
niﬁcant improvements in LVEF compared with sole frequency
control.6 The CASTLE-AF study further revealed that catheter
ablation for AF in patients with LVSD is associated with signif-
icant reduction of death from any cause and hospitalization
for worsening heart failure.8 Therefore, early and effective
treatment of cardiac arrhythmias seems to be very important
in the context of suspected AIC.9
In summary, this case report illustrates that
(i) severe AIC can induce multiple organ failure;
(ii) the diagnosis of AIC appears to be difﬁcult for many
physicians in clinical practice;
(iii) a careful evaluation of patients with LVSD and rhythm
disorders is essential to distinguish other causes from
reversible AIC;
(iv) an early aggressive anti-arrhythmic therapy in the con-
text of LVSD and concomitant rhythm disorders is crucial
for the patient’s outcome; and
(v) causal rhythm therapy leads to improvement of LV func-




Additional supporting information may be found online in the
Supporting Information section at the end of the article.
Video S1. Initial MRI.
Video S2. Follow-up MRI.
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